Press releases

December 21, 2018
Regulatory

New major order from China

Bactiguard has received a new order from Well Lead Medical (Well Lead) in China. The order will be delivered before the end of the year and generate revenues in the fourth quarter of approximately SEK 10 million.

December 21, 2018

Bactiguard expands partnership with Mediplast in Europe

Bactiguard expands its partnership with Mediplast to include Belgium, the Netherlands and Luxembourg. The previous agreement covered sales and distribution of Bactiguard’s product portfolio for infection prevention (BIP) in Scandinavia. Mediplast now becomes distributor of the BIP portfolio in six European countries.

December 05, 2018
Regulatory

CE-mark opens the door to billion-dollar market for orthopaedic trauma implants

Orthopaedic trauma implants in titanium with Bactiguard's coating for infection prevention have been CE marked and can, from now on, be sold and used in markets that apply EU quality standards. At the same time, the CE-mark opens possibilities for Bactiguard to establish new license agreements covering more markets. The global market for trauma implants is estimated at over 5 billion USD*.

November 20, 2018

Bactiguard Employer of the Year

Bactiguard was yesterday awarded “Visa vägen-priset” as Employer of the Year. The prize, referred to as Sweden's most important labour market price, is awarded to companies and individuals who lead the way in the labour market by opening opportunities for people with disabilities.

November 06, 2018
Regulatory

Interim report for Q3 2018

Following a very strong second quarter, the third quarter was a bit calmer, which is natural. Total revenues were somewhat higher than last year primarily due to increased license revenues from our largest partner BD, while BIP sales were lower. It is therefore reassuring that, so far this year, BIP sales have risen by as much as 80 percent. Even though the third quarter was not as strong as the second, developments so far this year are very positive.

October 31, 2018

Invitation to presentation of Bactiguard's interim report on November 6, 2018

Bactiguard Holding AB (publ) publishes the interim report for the third quarter on Tuesday November 6, 2018 at 8:00 CET.

October 18, 2018

Bactiguard receives product approval in Egypt

The product approval for Bactiguard’s urinary (Foley) catheters has been announced by the Egyptian Ministry of Health. This opens new opportunities for Bactiguard in providing effective infection prevention in the most populous country in North Africa and the Middle East.

October 12, 2018
Regulatory

Nomination Committee appointed for the Annual General Meeting 2019

The Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Wednesday 15 May 2019 at the company’s headoffice in Botkyrka, has been appoined. 

October 04, 2018

Bactiguard partners with Mediplast in Scandinavia

Bactiguard partners with Mediplast, a medical device company and healthcare supplier in the Nordic region, for sales and distribution in Sweden, Norway and Denmark. By using the Mediplast sales force, the Swedish healthcare providers can be covered more efficiently. At the same time, the collaboration provides a platform for launching the BIP portfolio in Norway and Denmark, markets where Bactiguard is not present today.

September 25, 2018

Bactiguard now available in Sweden's second largest county

In October last year, Bactiguard won a tender for urinary catheters for Sweden’s second largest county, the Västra Götaland region (VGR), but the tender was appealed in other areas than Bactiguard's products. Now the contract is in place, and healthcare providers in both primary and secondary care and 49 municipalities in the region can purchase Bactiguard's urinary catheters for infection prevention.

Pages